Pharming Group NV (PHAR)
9.68
-0.12
(-1.22%)
USD |
NASDAQ |
Oct 06, 16:00
Pharming Group Price to Book Value : 2.666 for Oct. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 2.666 |
| October 05, 2026 | 2.699 |
| October 02, 2026 | 2.685 |
| October 01, 2026 | 2.740 |
| September 30, 2026 | 2.751 |
| September 29, 2026 | 2.756 |
| September 28, 2026 | 2.897 |
| September 25, 2026 | 2.880 |
| September 24, 2026 | 2.875 |
| September 23, 2026 | 2.966 |
| September 22, 2026 | 3.101 |
| September 21, 2026 | 2.977 |
| September 18, 2026 | 2.905 |
| September 17, 2026 | 2.968 |
| September 16, 2026 | 2.919 |
| September 15, 2026 | 2.905 |
| September 14, 2026 | 2.980 |
| September 11, 2026 | 3.087 |
| September 10, 2026 | 2.975 |
| September 09, 2026 | 3.021 |
| September 08, 2026 | 3.167 |
| September 04, 2026 | 3.092 |
| September 03, 2026 | 3.156 |
| September 02, 2026 | 3.084 |
| September 01, 2026 | 3.059 |
| Date | Value |
|---|---|
| August 31, 2026 | 3.161 |
| August 28, 2026 | 3.222 |
| August 27, 2026 | 3.244 |
| August 26, 2026 | 3.291 |
| August 25, 2026 | 3.241 |
| August 24, 2026 | 3.156 |
| August 21, 2026 | 3.263 |
| August 20, 2026 | 3.216 |
| August 19, 2026 | 3.263 |
| August 18, 2026 | 3.280 |
| August 17, 2026 | 3.247 |
| August 14, 2026 | 3.227 |
| August 13, 2026 | 3.401 |
| August 12, 2026 | 3.258 |
| August 11, 2026 | 3.368 |
| August 10, 2026 | 3.125 |
| August 07, 2026 | 3.015 |
| August 06, 2026 | 2.988 |
| August 05, 2026 | 2.940 |
| August 04, 2026 | 2.825 |
| August 03, 2026 | 2.704 |
| July 31, 2026 | 2.776 |
| July 30, 2026 | 2.960 |
| July 29, 2026 | 3.307 |
| July 28, 2026 | 3.541 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ProQR Therapeutics NV | 2.532 |
| NewAmsterdam Pharma Co. NV | 4.194 |
| argenx SE | -- |
| Nektar Therapeutics | 1.488 |
| ACADIA Pharmaceuticals, Inc. | 2.589 |
Price to Book Value Related Metrics
| PE Ratio | 77.88 |
| PS Ratio | 1.946 |
| Price to Free Cash Flow | 27.73 |
| Price | 9.68 |
| Earnings Yield | 1.28% |
| Market Cap | 685.13M |
| Operating PE Ratio | 31.88 |
| Normalized PE Ratio | 43.45 |